Michal Bassani-Sternberg

Michal Bassani-Sternberg has advanced neoantigen prediction through large-scale immunopeptidomics, using mass spectrometry to directly identify peptides presented on MHC molecules in tumors. Her work has established training datasets that dramatically improved computational neoantigen prediction algorithms. She has developed integrated workflows combining immunopeptidomics with genomics to identify actionable neoantigens for personalized cancer vaccine design.